High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
暂无分享,去创建一个
[1] D. Solomon,et al. Validity of physician-reported hospitalized infections in a US arthritis registry. , 2009, Rheumatology.
[2] W. Bishai,et al. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry , 2009, Annals of the rheumatic diseases.
[3] T. Pincus,et al. Mortality in rheumatoid arthritis: 2008 update. , 2008, Clinical and experimental rheumatology.
[4] T. Einarson,et al. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events , 2008, Annals of the rheumatic diseases.
[5] M. Abrahamowicz,et al. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[6] Hyon K. Choi,et al. The risk of hospitalized infection in patients with rheumatoid arthritis. , 2008, The Journal of rheumatology.
[7] T. Therneau,et al. The widening mortality gap between rheumatoid arthritis patients and the general population. , 2007, Arthritis and rheumatism.
[8] C. Kelly,et al. Acute lower respiratory tract infections in patients with rheumatoid arthritis. , 2007, The Journal of rheumatology.
[9] J. Smolen,et al. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. , 2007, Best practice & research. Clinical rheumatology.
[10] M. Hudson,et al. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. , 2007, Rheumatology.
[11] Sebastian Schneeweiss,et al. Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis , 2007 .
[12] H. Paulus,et al. Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort , 2007, Annals of the rheumatic diseases.
[13] J. Allison,et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. , 2007, Arthritis and rheumatism.
[14] A. Silman,et al. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. , 2006, Arthritis and rheumatism.
[15] Matthias Schneider,et al. Infections in patients with rheumatoid arthritis treated with biologic agents. , 2005, Arthritis and rheumatism.
[16] J. Kremer,et al. The CORRONA database. , 2006, Autoimmunity reviews.
[17] J. Smolen,et al. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.
[18] H. Oiwa,et al. Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study , 2005, Annals of the rheumatic diseases.
[19] D. Symmons,et al. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. , 2003, The Journal of rheumatology.
[20] L A Criswell,et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women’s Health Study , 2002, Annals of the rheumatic diseases.
[21] S. Gabriel,et al. Predictors of infection in rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[22] S. Gabriel,et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. , 2002, Arthritis and rheumatism.
[23] W. Pan. Akaike's Information Criterion in Generalized Estimating Equations , 2001, Biometrics.
[24] J. Alcocer-Varela,et al. Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. , 1998, The Journal of rheumatology.
[25] P. van Riel,et al. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. , 1998, Arthritis and rheumatism.
[26] Peter L. Brooks,et al. Visualizing data , 1997 .
[27] H. Kautiainen,et al. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.
[28] M. Laakso,et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. , 1985, British medical journal.
[29] P. Sarzi-Puttini,et al. Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients. , 2009, Autoimmunity reviews.
[30] Jeffrey N Katz,et al. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[31] E. Arnesen,et al. Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study , 2001, Clinical Rheumatology.
[32] P. Allebeck. Increased mortality in rheumatoid arthritis. , 1982, Scandinavian Journal of Rheumatology.
[33] P. Allebeck. Increased Mortality in Rheumatoid Arthritis: The Use of a Medical Information System for Assessment of Death Risks , 1982 .
[34] J. Baum. Infection in rheumatoid arthritis. , 1971, Arthritis and rheumatism.